27 research outputs found

    EnvironmetaI Education through Outdoor Education

    Get PDF
    1996Environmental problems are mounting at an unprecedented rate in our society. The news media reported recently that fish died by hundreds of thousands in a river due to waterborne toxic wastes which were illegally discharged into a river. The large Shi-hwa lake, a reclaimed lake in tidal area on the west coast near the city of Ansan, where one of the largest industrial estates in the capital region is located, had to release its water back into the ocean because the water was so polluted by waterborne industrial wastes and municipal wastes that it could not be irrigated onto farm land. These are only some of examples to indicate how our environmental problems are increasingly serious, not only by a few industrial plant managers' illegal actions and by our negligent administrative practices in applying strict environmental laws against illegal and harmful environmental damages, but also by the irresponsible behavior of the public in general

    Dual Fistulas of Ascending Aorta and Coronary Artery to Pulmonary Artery

    Get PDF
    Coronary artery fistula to pulmonary artery is common. However, to the best of our knowledge, a case of coronary artery fistula to pulmonary artery associated with aortopulmonary fistula remains unreported. We herein report a 64-year-old female with a left anterior descending coronary artery and ascending aorta to pulmonary artery fistulas, and conduct a brief review of the literature

    Variation block-based genomics method for crop plants

    Get PDF
    BACKGROUND: In contrast with wild species, cultivated crop genomes consist of reshuffled recombination blocks, which occurred by crossing and selection processes. Accordingly, recombination block-based genomics analysis can be an effective approach for the screening of target loci for agricultural traits. RESULTS: We propose the variation block method, which is a three-step process for recombination block detection and comparison. The first step is to detect variations by comparing the short-read DNA sequences of the cultivar to the reference genome of the target crop. Next, sequence blocks with variation patterns are examined and defined. The boundaries between the variation-containing sequence blocks are regarded as recombination sites. All the assumed recombination sites in the cultivar set are used to split the genomes, and the resulting sequence regions are termed variation blocks. Finally, the genomes are compared using the variation blocks. The variation block method identified recurring recombination blocks accurately and successfully represented block-level diversities in the publicly available genomes of 31 soybean and 23 rice accessions. The practicality of this approach was demonstrated by the identification of a putative locus determining soybean hilum color. CONCLUSIONS: We suggest that the variation block method is an efficient genomics method for the recombination block-level comparison of crop genomes. We expect that this method will facilitate the development of crop genomics by bringing genomics technologies to the field of crop breeding

    Variation block-based genomics method for crop plants

    Get PDF
    This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.Abstract Background In contrast with wild species, cultivated crop genomes consist of reshuffled recombination blocks, which occurred by crossing and selection processes. Accordingly, recombination block-based genomics analysis can be an effective approach for the screening of target loci for agricultural traits. Results We propose the variation block method, which is a three-step process for recombination block detection and comparison. The first step is to detect variations by comparing the short-read DNA sequences of the cultivar to the reference genome of the target crop. Next, sequence blocks with variation patterns are examined and defined. The boundaries between the variation-containing sequence blocks are regarded as recombination sites. All the assumed recombination sites in the cultivar set are used to split the genomes, and the resulting sequence regions are termed variation blocks. Finally, the genomes are compared using the variation blocks. The variation block method identified recurring recombination blocks accurately and successfully represented block-level diversities in the publicly available genomes of 31 soybean and 23 rice accessions. The practicality of this approach was demonstrated by the identification of a putative locus determining soybean hilum color. Conclusions We suggest that the variation block method is an efficient genomics method for the recombination block-level comparison of crop genomes. We expect that this method will facilitate the development of crop genomics by bringing genomics technologies to the field of crop breeding

    Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

    Get PDF
    Background: Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. // Methods: We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung's disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. // Findings: We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung's disease) from 264 hospitals (89 in high-income countries, 166 in middle-income countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58ยท0%) were male. Median gestational age at birth was 38 weeks (IQR 36โ€“39) and median bodyweight at presentation was 2ยท8 kg (2ยท3โ€“3ยท3). Mortality among all patients was 37 (39ยท8%) of 93 in low-income countries, 583 (20ยท4%) of 2860 in middle-income countries, and 50 (5ยท6%) of 896 in high-income countries (p<0ยท0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90ยท0%] of ten in low-income countries, 97 [31ยท9%] of 304 in middle-income countries, and two [1ยท4%] of 139 in high-income countries; pโ‰ค0ยท0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2ยท78 [95% CI 1ยท88โ€“4ยท11], p<0ยท0001; middle-income vs high-income countries, 2ยท11 [1ยท59โ€“2ยท79], p<0ยท0001), sepsis at presentation (1ยท20 [1ยท04โ€“1ยท40], p=0ยท016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4โ€“5 vs ASA 1โ€“2, 1ยท82 [1ยท40โ€“2ยท35], p<0ยท0001; ASA 3 vs ASA 1โ€“2, 1ยท58, [1ยท30โ€“1ยท92], p<0ยท0001]), surgical safety checklist not used (1ยท39 [1ยท02โ€“1ยท90], p=0ยท035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1ยท96, [1ยท41โ€“2ยท71], p=0ยท0001; parenteral nutrition 1ยท35, [1ยท05โ€“1ยท74], p=0ยท018). Administration of parenteral nutrition (0ยท61, [0ยท47โ€“0ยท79], p=0ยท0002) and use of a peripherally inserted central catheter (0ยท65 [0ยท50โ€“0ยท86], p=0ยท0024) or percutaneous central line (0ยท69 [0ยท48โ€“1ยท00], p=0ยท049) were associated with lower mortality. // Interpretation: Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between low-income, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030

    -็งปไฝ์™€ ํŒ๋ จํ•œ ไฝEํž˜ๅฝข้กฏ์˜ ้ธๅฅฝ์— ๊ด€ํ•œ ๆ˜ญ็ฉถ- Mobile Home ๅฑ…ไฝ่€…๋“ค์˜ ๊ฒฝ์šฐ

    No full text
    ้ƒฝๅธ‚ไฝ๏จ„ ํ˜•ํƒœ๋Š” ๊ฐ ๅฎถๅฃ์˜ ์ฃผํƒ์„ ์ •์— ๊ด€ํ•œ ํ–‰์œ„์˜ ํ•œ ํ‘œํ˜„์ด๋‹ค. ๋น„๋ก ํ•œ ๊ฐœ์ธ์˜ ์˜ํ–ฅ์€ ๋ฏธ๋ฏธํ•œ ๊ฒƒ์ด๋ผ ํ• ์ง€๋ผ๋„, ์ด๋“ค์˜ ์ง‘ํ•ฉ์€ ์ „์ฒด์ ์œผ๋กœ ๋ณด๋ฉด ้ƒฝๅธ‚ๆ™ฏ่ง€์˜ ํŠน์ง•์„ ๋‚˜ํƒ€๋‚ธ๋‹ค. ๋„์‹œ ์ง€์—ญ์—์„œ ๅฑ…ไฝๅœฐ ์ด๋™์— ๊ด€ํ•œ ์—ฐ๊ตฌ๋Š” ๋งŽ์ด ํ–‰ํ•ด์กŒ๋‹ค. ์ด๋“ค ์—ฐ๊ตฌ๋Š” ์ฃผ๋กœ ๊ฐ ๊ฐœ์ธ์ด ๋‹ค๋ฅธ ์žฅ์†Œ๋กœ ็งปไฝ๋ฅผ ๊ฒฐ์ •ํ•˜๋Š”๋ฐ ์˜ํ–ฅ์„ ์ฃผ๋Š” ์š”์ธ๋“ค์„, ๋˜๋Š” ๊ทธ ๊ฒฐ์ •๊ณผ์ •์— ๋ฏธ์น˜๋Š” ์‚ฌํ•ญ๋“ค์„ ๋ถ„์„ํ•˜๋Š”๋ฐ ์ฃผ๋กœ ๊ด€์‹ฌ์„ ๊ฐ€์กŒ๋‹ค. ๊ทธ๋Ÿฌ๋‚˜ ํ•œ ไฝ๏จ„ ํ˜•ํƒœ์—์„œ ๋‹ค๋ฅธ ํ˜•ํƒœ๋กœ์˜ ็งปไฝ์— ๊ด€ํ•œ ์—ฐ๊ตฌ๋Š” ๊ฑฐ์˜ ์—†์—ˆ๋‹ค. ์ด๋Ÿฌํ•œ ็งปไฝ๋Š” ํ•œ ๅฎถๅบญ์˜ ํ•„์š”์™€ ๆฌฒๆฑ‚์˜ ๋ณ€ํ™”๋ฅผ ์ถฉ์กฑ์‹œํ‚ค๋Š” ์ค‘์š”ํ•œ ๊ณผ์ •์˜ ํ•˜๋‚˜์ด๋‹ค. ๋„์‹œ๊ณ„ํš์ด๋‚˜, ํ† ์ง€์ด์šฉ๊ณ„ํš์—์„œ ๊ฐ ์ฃผํƒํ˜•ํƒœ์˜ ์ˆ˜์š”๋ฅผ ์ •ํ™•ํžˆ ์˜ˆ์ธกํ•  ์ˆ˜ ์žˆ์Œ์ด ํ•„์š”ํ•˜๊ณ , ๊ฐ ๊ฐœ์ธ์˜ ์ƒ์ดํ•œ ์ฃผํƒํ˜•ํƒœ์˜ ์„ ํƒ์— ์˜ํ–ฅ์„ ์ฃผ๋Š” ์š”์ธ์„ ์ดํ•ดํ•˜๋Š” ๊ฒƒ์€ ํšจ๊ณผ์ ์ธ ํ† ์ง€์ด์šฉ ๊ณ„ํš์„ ์ˆ˜๋ฆฝํ•˜๋Š”๋ฐ ํฌ๊ฒŒ ๊ณตํ—Œํ•  ์ˆ˜ ์žˆ๋‹ค. ์ด ์—ฐ๊ตฌ์˜ ๋ชฉ์ ์€ ๋„์‹œ์ง€์—ญ์—์„œ ํ•œ ์ฃผํƒํ˜•ํƒœ์—์„œ ๋‹ค๋ฅธ ํ˜•ํƒœ๋กœ ็งปไฝํ•˜๋Š”๋ฐ ๋ฏธ์น˜๋Š” ์ค‘์š”ํ•œ ์š”์ธ์„ ๋ถ„์„ํ•˜๋Š” ๊ฒƒ์ด๋‹ค. ์ด ์กฐ์‚ฌ์—๋Š” ๋ฏธ๊ตญ ํ…Œ๋„ค์”จ์ฃผ์˜ Blount ์นด์šดํ‹ฐ ๋ฐ Knox ์นด์šดํ‹ฐ์— ๊ฑฐ์ฃผํ•˜๊ณ  ์žˆ๋˜ 280๋ช…์˜ mobile home ๅฑ…ไฝ่€…๋ฅผ ๋Œ€์ƒ์œผ๋กœ ์งˆ๋ฌธ์ง€๋ฅผ ์‚ฌ์šฉํ•œ ๊ฐœ๋ณ„๋ฉด๋‹ด์— ์˜ํ•œ ์ž๋ฃŒ๋ฅผ ์‚ฌ์šฉํ•˜์˜€๋‹ค. ์ด๋“ค ์ž๋ฃŒ๋ฅผ ๅคงๅˆฅํ•˜๋ฉด, ์„ธ๋Œ€์ฃผ์˜ ์—ฐ๋ น, ์ฃผํƒํ™˜๊ฒฝ, ์„ธ๋Œ€์ฃผ์˜ ์‚ฌํšŒ์  ๋ฐ ๊ฒฝ์ œ์  ์‚ฌ์‹ค, ไฝๅฎ…็ซ‹ๅœฐ, ๊ทธ๋ฆฌ๊ณ  ํ˜„์žฌ์˜ ์ฃผํƒ์„ ์„ ํƒํ•œ ๊ธฐํƒ€ ์ด์œ ์— ๊ด€ํ•œ ์‚ฌํ•ญ๋“ค์ด๋‹ค. Discriminant ๋ถ„์„ ๋ฐฉ๋ฒ•์„ ์‚ฌ์šฉํ•œ ์ด ์—ฐ๊ตฌ๋Š” ๋‘ ๊ฐ€์ง€๋กœ ๋‚˜๋ˆ„์–ด์ ธ ์žˆ๋‹ค : ๊ทธ์ค‘ ํ•˜๋‚˜๋Š” ๊ณผ๊ฑฐ์˜ ์ฃผํƒํ˜•ํƒœ์—์„œ ํ˜„์žฌ์˜ ์ฃผํƒํ˜•ํƒœ์—๋กœ์˜ ็งปไฝ ; ๋‹ค๋ฅธ ํ•œ๋‚˜๋Š” ํ˜„์žฌ์˜ ์ฃผํƒ์—์„œ ์ด์‚ฌ๋ฅผ ๊ฐˆ ๊ฒฝ์šฐ ํฌ๋งํ•˜๋Š” ์ฃผํƒํ˜•ํƒœ์— ๊ด€ํ•œ ๋ถ„์„์ด๋‹ค

    Apoptotic death of prostate cancer cells by a gonadotropin-releasing hormone-II antagonist.

    No full text
    Gonadotropin-releasing hormone-I (GnRH-I) has attracted strong attention as a hormonal therapeutic tool, particularly for androgen-dependent prostate cancer patients. However, the androgen-independency of the cancer in advanced stages has spurred researchers to look for new medical treatments. In previous reports, we developed the GnRH-II antagonist Trp-1 to inhibit proliferation and stimulate the autophagic death of various prostate cancer cells, including androgen-independent cells. We further screened many GnRH-II antagonists to identify molecules with higher efficiency. Here, we investigated the effect of SN09-2 on the growth of PC3 prostate cancer cells. SN09-2 reduced the growth of prostate cancer cells but had no effect on cells derived from other tissues. Compared with Trp-1, SN09-2 conspicuously inhibited prostate cancer cell growth, even at low concentrations. SN09-2-induced PC3 cell growth inhibition was associated with decreased membrane potential in mitochondria where the antagonist was accumulated, and increased mitochondrial and cytosolic reactive oxygen species. SN09-2 induced lactate dehydrogenase release into the media and annexin V-staining on the PC3 cell surface, suggesting that the antagonist stimulated prostate cancer cell death by activating apoptotic signaling pathways. Furthermore, cytochrome c release from mitochondria to the cytosol and caspase-3 activation occurred in a concentration- and time-dependent manner. SN09-2 also inhibited the growth of PC3 cells xenotransplanted into nude mice. These results demonstrate that SN09-2 directly induces mitochondrial dysfunction and the consequent ROS generation, leading to not only growth inhibition but also apoptosis of prostate cancer cells

    SN09-2 stimulates cytochrome c release from mitochondria and caspase-3 activation.

    No full text
    <p>(Aโ€“D) Western blotting of cytochrome c in the cytosolic and mitochondrial fractions (A, C) PC3 cells were treated with different concentrations of SN09-2 for 24 h and fractionated into cytosol and mitochondria. 20 ยตg lysates from each fraction were used for SDS-PAGE and western blotting with anti-cytochrome c antibodies. (B, D) Cells treated with 10 ยตM SN09-2 were harvested at different time points, and then fractionated. (C, D) The signal intensity of each blot was measured and shown as graphs (E) PC3 cells treated with 10 ยตM SN09-2 were harvested at different time points, and used for western blotting with anti-caspase-3 or a cleaved form of caspase-3 antibodies. The amount of loaded proteins was normalized with anti-ฮฒ-actin antibodies. (F) SN09-2-treated PC3 cells on cover slips were labeled with antibodies for active cleaved caspase-3 and anti-ฮฒ-actin, and then briefly stained with Hoechst33342. Fluorescence signals were observed under a confocal microscope.</p

    Subcellular localization of SN09-2 in PC3 cells.

    No full text
    <p>Cells were incubated with FITC-conjugated SN09-2 and MitoTracker. After washing, the cells were briefly labeled with Hoechst33342 (for nucleus staining). The images were taken under a confocal microscope. Red: MitoTracker, Green: FITC-SN09-2, Blue: Hoechst33342</p

    SN09-2 inhibits prostate cancer cell growth.

    No full text
    <p>(A) Molecular sequences of GnRH-II, Trp-1, and SN09-2 (B) PC3 cells were incubated in RPMI media containing various concentrations of FBS and exposed to 10 ยตM SN09-2 for 4 days. The number of viable cells was counted under a light microscope. (C) PC3, Du145, LNCaP, HeLa, and DLD1 cells were incubated with 5% FBS media containing 10 mM SN09-2 or DMSO for 3 days. (D) PC3 cells were treated with different concentrations of Trp-1 or SN09-2 for 3 days, and then viable cells were counted under the light microscope. The cell number of each group was compared with the DMSO-treated group. CTL: DMSO-treated. (E) PC3 cells were treated with various concentrations of SN09-2 for 3 days. Using culture supernatants from each group, LDH activity was determined as described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0099723#s2" target="_blank">Materials and Methods</a>. Data are means ยฑ S.E. *, <i>p<</i>0.05; **, <i>p<</i>0.01, versus control.</p
    corecore